A carregar...

Prospective Study of Withdrawal of Antiviral Therapy in Patients with Chronic Hepatitis B after Prolonged Virological Response

Nucleoside analogue (NA) therapy for chronic hepatitis B (CHB) is associated with improved clinical outcomes, but usually requires long‐term use. Whether treatment can be safely withdrawn and the factors associated with post‐withdrawal outcome are not well defined. To assess long‐term outcomes after...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hepatology Communications
Main Authors: Naveen Gara, Michele M. Tana, Meera Kattapuram, Sungyoung Auh, Lauren Sullivan, Nancy Fryzek, Mary Walter, Regina Umarova, Xiongce Zhao, Gavin Cloherty, Edward Doo, Theo Heller, T. Jake Liang, Marc G. Ghany
Formato: Artigo
Publicado em: Wolters Kluwer Health/LWW 2021-11-01
Acesso em linha:https://doi.org/10.1002/hep4.1761
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!